Prevalence and clinical significance of cardiac arrhythmia in Anderson-Dabry disease

American Journal of Cardiology

Volumn 96, Issue 6, 2005, Pages 842-846

  Shah, Jaymin S ^a   Hughes, Derralynn A ^b   Sachdev, Bhavesh ^a   Tome, Maite ^a   Ward, Deirdre ^a   Lee, Philip ^c   Mehta, Atul B ^b   Elliott, Perry M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; LEAD;

ADOLESCENT; ADULT; AGING; ANDERSON FABRY DISEASE; ANGINA PECTORIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; BIOLOGICAL MODEL; BODY MASS; BRADYCARDIA; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; DEFIBRILLATOR; DEMOGRAPHY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; ENZYME DEFICIENCY; EVALUATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE WALL; HEART VENTRICLE SIZE; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; LYSOSOME STORAGE DISEASE; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; PREDICTION; PRIORITY JOURNAL; SINUS NODE; SUDDEN DEATH; X CHROMOSOME LINKAGE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FABRY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE;

EID: 24944513802     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.05.033     Document Type: Article

References (19)

1. R.J. Desnick, Y.A. Ioannou, C.M. Eng a-Galactosidase A deficiency Fabry disease C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Bases of Inherited Disease 8th Ed 2001 McGraw-Hill New York, New York 3733 3774
2. A. Mehta, R. Ricci, U. Widmer, F. Dehout, A. Garcia de Lorenzo, C. Kampmann, A. Linhart, G. Sunder-Plassmann, M. Ries, M. Beck Fabry disease defined baseline clinical manifestations of 366 patients in the Fabry Outcome Survey Eur J Clin Invest 34 2004 236 242
3. B. Sachdev, T. Takenaka, H. Teraguchi, C. Tei, P. Lee, W.J. McKenna, P.M. Elliott Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy Circulation 105 2002 1407 1411
4. The Criteria Committee of the New York Heart Association Nomenclature and Criteria for Diagnosis 9th Ed 1994 Little Brown Boston, Massachusetts
5. D.W. Romhilt, E.H. Estes Jr A point-score system for the ECG diagnosis of left ventricular hypertrophy Am Heart J 75 1968 752 758
6. S. Bellet Clinical Disorders of the Heart Beat 3rd Ed 1971 Lea & Febiger Philadelphia, Pennsylvania
7. V. Fuster, L.E. Ryden, R.W. Asinger, D.S. Cannom, H.J. Crijns, R.L. Frye, J.L. Halperin, G.N. Kay, W.W. Klein, S. Levy ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Circulation 104 2001 2118 2150
8. R.B. Devereux, D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, I. Sachs, N. Reichek Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings Am J Cardiol 57 1986 450 458
9. C. Kampmann, F. Baehner, C. Whybra, C. Martin, C.M. Wiethoff, M. Ries, A. Gal, M. Beck Cardiac manifestations of Anderson-Fabry disease in heterozygous females J Am Coll Cardiol 40 2002 1668 1674
10. Y. Nagao, H. Nakashima, Y. Fukuhara, M. Shimmoto, A. Oshima, Y. Ikari, Y. Mori, H. Sakuraba, Y. Suzuki Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A Clin Genet 39 1991 233 237
11. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, J.V. Selby, D.E. Singer Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
12. R.J. Desnick, L.C. Blieden, H.L. Sharp, P.J. Hofschire, J.H. Moller Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies Circulation 54 1976 818 825
13. V.J. Ferrans, R.G. Hibbs, C.D. Burda The heart in Fabry's disease. A histochemical and electron microscopic study Am J Cardiol 24 1969 95 110
14. A.E. Becker, R. Schoorl, A.G. Balk, R.M. van der Heide Cardiac manifestations of Fabry's disease. Report of a case with mitral insufficiency and electrocardiographic evidence of myocardial infarction Am J Cardiol 36 1975 829 835
15. M. Elleder, V. Bradova, F. Smid, M. Budesinsky, K. Harzer, B. Kustermann-Kuhn, J. Ledvinova, Belohlavek, V. Kral, V. Dorazilova Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy Virchows Arch A Pathol Anat Histopathol 417 1990 449 455
16. J.C. Moon, B. Sachdev, A.G. Elkington, W.J. McKenna, A. Mehta, D.J. Pennell, P.J. Lee, P.M. Elliott Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium Eur Heart J 24 2003 2151 2155
17. Y. Doi, G. Toda, K. Yano Sisters with atypical Fabry's disease with complete atrioventricular block Heart 89 2003 e2
18. Y. Ikari, K. Kuwako, T. Yamaguchi Fabry's disease with complete atrioventricular block histological evidence of involvement of the conduction system Br Heart J 68 1992 323 325
19. A. Yokoyama, M. Yamazoe, A. Shibata A case of heterozygous Fabry's disease with a short PR interval and giant negative T waves Br Heart J 57 1987 296 299